Cargando…

Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016

BACKGROUND: Laboratory-confirmed cases of Shiga toxin-producing Escherichia coli (STEC) have been notifiable to the National Notification System for Infectious Diseases in Switzerland since 1999. Since 2015, a large increase in case numbers has been observed. Around the same time, syndromic multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Fabienne Beatrice, Saucy, Apolline, Schmutz, Claudia, Mäusezahl, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441602/
https://www.ncbi.nlm.nih.gov/pubmed/32820716
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.33.1900584
_version_ 1783573323282644992
author Fischer, Fabienne Beatrice
Saucy, Apolline
Schmutz, Claudia
Mäusezahl, Daniel
author_facet Fischer, Fabienne Beatrice
Saucy, Apolline
Schmutz, Claudia
Mäusezahl, Daniel
author_sort Fischer, Fabienne Beatrice
collection PubMed
description BACKGROUND: Laboratory-confirmed cases of Shiga toxin-producing Escherichia coli (STEC) have been notifiable to the National Notification System for Infectious Diseases in Switzerland since 1999. Since 2015, a large increase in case numbers has been observed. Around the same time, syndromic multiplex PCR started to replace other diagnostic methods in standard laboratory practice for gastrointestinal pathogen testing, suggesting that the increase in notified cases is due to a change in test practices and numbers. AIM: This study examined the impact of changes in diagnostic methods, in particular the introduction of multiplex PCR panels, on routine STEC surveillance data in Switzerland. METHODS: We analysed routine laboratory data from 11 laboratories, which reported 61.9% of all STEC cases from 2007 to 2016 to calculate the positivity, i.e. the rate of the number of positive STEC tests divided by the total number of tests performed. RESULTS: The introduction of multiplex PCR had a strong impact on STEC test frequency and identified cases, with the number of tests performed increasing sevenfold from 2007 to 2016. Still, age- and sex-standardised positivity increased from 0.8% in 2007 to 1.7% in 2016. CONCLUSION: Increasing positivity suggests that the increase in case notifications cannot be attributed to an increase in test numbers alone. Therefore, we cannot exclude a real epidemiological trend for the observed increase. Modernising the notification system to address current gaps in information availability, e.g. diagnostic methods, and improved triangulation of clinical presentation, diagnostic and serotype information are needed to deal with emerging disease and technological advances.
format Online
Article
Text
id pubmed-7441602
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-74416022020-08-28 Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016 Fischer, Fabienne Beatrice Saucy, Apolline Schmutz, Claudia Mäusezahl, Daniel Euro Surveill Research BACKGROUND: Laboratory-confirmed cases of Shiga toxin-producing Escherichia coli (STEC) have been notifiable to the National Notification System for Infectious Diseases in Switzerland since 1999. Since 2015, a large increase in case numbers has been observed. Around the same time, syndromic multiplex PCR started to replace other diagnostic methods in standard laboratory practice for gastrointestinal pathogen testing, suggesting that the increase in notified cases is due to a change in test practices and numbers. AIM: This study examined the impact of changes in diagnostic methods, in particular the introduction of multiplex PCR panels, on routine STEC surveillance data in Switzerland. METHODS: We analysed routine laboratory data from 11 laboratories, which reported 61.9% of all STEC cases from 2007 to 2016 to calculate the positivity, i.e. the rate of the number of positive STEC tests divided by the total number of tests performed. RESULTS: The introduction of multiplex PCR had a strong impact on STEC test frequency and identified cases, with the number of tests performed increasing sevenfold from 2007 to 2016. Still, age- and sex-standardised positivity increased from 0.8% in 2007 to 1.7% in 2016. CONCLUSION: Increasing positivity suggests that the increase in case notifications cannot be attributed to an increase in test numbers alone. Therefore, we cannot exclude a real epidemiological trend for the observed increase. Modernising the notification system to address current gaps in information availability, e.g. diagnostic methods, and improved triangulation of clinical presentation, diagnostic and serotype information are needed to deal with emerging disease and technological advances. European Centre for Disease Prevention and Control (ECDC) 2020-08-20 /pmc/articles/PMC7441602/ /pubmed/32820716 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.33.1900584 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research
Fischer, Fabienne Beatrice
Saucy, Apolline
Schmutz, Claudia
Mäusezahl, Daniel
Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016
title Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016
title_full Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016
title_fullStr Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016
title_full_unstemmed Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016
title_short Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016
title_sort do changes in stec diagnostics mislead interpretation of disease surveillance data in switzerland? time trends in positivity, 2007 to 2016
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441602/
https://www.ncbi.nlm.nih.gov/pubmed/32820716
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.33.1900584
work_keys_str_mv AT fischerfabiennebeatrice dochangesinstecdiagnosticsmisleadinterpretationofdiseasesurveillancedatainswitzerlandtimetrendsinpositivity2007to2016
AT saucyapolline dochangesinstecdiagnosticsmisleadinterpretationofdiseasesurveillancedatainswitzerlandtimetrendsinpositivity2007to2016
AT schmutzclaudia dochangesinstecdiagnosticsmisleadinterpretationofdiseasesurveillancedatainswitzerlandtimetrendsinpositivity2007to2016
AT mausezahldaniel dochangesinstecdiagnosticsmisleadinterpretationofdiseasesurveillancedatainswitzerlandtimetrendsinpositivity2007to2016